146 related articles for article (PubMed ID: 21380781)
1. A Phase II trial of Zoladex combined with CEF chemotherapy as neoadjuvant therapy in premenopausal women with hormone-responsive, operable breast cancer.
Zhang S; Zhang C; Liu J; Qin L; Cui S; Zhang J
Med Oncol; 2012 Jun; 29(2):479-85. PubMed ID: 21380781
[TBL] [
